US News & World Report: Lung cancer screening and COVID-19
December 21, 2020
New UC research shows a dangerous trend in lung cancer caused by the pandemic.
December 21, 2020
New UC research shows a dangerous trend in lung cancer caused by the pandemic.
May 26, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.
January 5, 2021
Drugs.com reports that COVID-19 has caused significant disruption in lung cancer screening.
January 21, 2021
UC research, published in JAMA Oncology, shows that chemotherapy before surgery for some pancreatic cancer patients may not improve survival rates.
March 16, 2021
Months after mammograms, colonoscopies and other routine cancer screenings, like lung cancer screenings, were suspended because of the pandemic, researchers are studying the impact.
December 17, 2020
A recent study led by University of Cincinnati Cancer Center researchers shows the impact the pandemic had on lung cancer screening, which experts say could be bad for both screening programs in general and for the overall well-being of patients.
March 18, 2020
UC's Abhinav Sidana comments on new research that shows African American men are less likely to use a targeted biopsy option for prostate cancer.
September 29, 2020
By examining preexisting research for other conditions, researchers at the University of Cincinnati have found a potential treatment that could be applied to COVID-19.
September 7, 2022
University of Cincinnati researchers recently published study results in JAMA Otolaryngology showing that administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.